Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurence Collette

Showing results (51-60 of 155) with videos related to

Pageof 16
Sort By:
Cancer|April 3, 2007
Short- vs long-term androgen suppression plus external beam radiation therapy and survival in men of advanced age with node-negative high-risk adenocarcinoma of the prostateAnthony V D'Amico, James W Denham, Michel Bolla, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 28, 2005
Quality assurance in the EORTC phase III randomised 'boost vs. no boost' trial for breast conserving therapy: comparison of the results of two individual case reviews performed early and late during the accrual periodPhilip M P Poortmans, Fatma Ataman, Jacques Bernard Davis, et al.
The New England Journal of Medicine|August 19, 2007
Prophylactic cranial irradiation in extensive small-cell lung cancerBen Slotman, Corinne Faivre-Finn, Gijs Kramer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 21, 2009
EORTC-ROG expert opinion: radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction and the stomachOscar Matzinger, Erich Gerber, Zvi Bernstein, et al.
European Journal of Cancer (Oxford, England : 1990)|January 24, 2007
Quality assurance in breast cancer: EORTC experiences in the phase III trial on irradiation of the internal mammary nodesElena Musat, Philip Poortmans, Walter Van den Bogaert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2005
Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results--EORTC 22921Jean-François Bosset, Gilles Calais, Laurent Mineur, et al.
Journal of Clinical Epidemiology|April 18, 2022
Representativeness of trial participants: linking the EORTC boost-no boost trial to the Netherlands cancer registryAnouk Neven, Marissa C van Maaren, Kay Schreuder, et al.
JNCI Cancer Spectrum|July 31, 2019
A Systematic Review and Recommendation for Reporting of Surrogate Endpoint Evaluation Using Meta-analysesWanling Xie, Susan Halabi, Jayne F Tierney, et al.
The New England Journal of Medicine|September 15, 2006
Chemotherapy with preoperative radiotherapy in rectal cancerJean-François Bosset, Laurence Collette, Gilles Calais, et al.
European Urology|June 21, 2002
Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studiesMaurizio Brausi, Laurence Collette, Karlheinz Kurth, et al.
Pageof 16

Showing results (51-60 of 155) with videos related to

Sort By:
Pageof 16
Cancer|April 3, 2007
Short- vs long-term androgen suppression plus external beam radiation therapy and survival in men of advanced age with node-negative high-risk adenocarcinoma of the prostateAnthony V D'Amico, James W Denham, Michel Bolla, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 28, 2005
Quality assurance in the EORTC phase III randomised 'boost vs. no boost' trial for breast conserving therapy: comparison of the results of two individual case reviews performed early and late during the accrual periodPhilip M P Poortmans, Fatma Ataman, Jacques Bernard Davis, et al.
The New England Journal of Medicine|August 19, 2007
Prophylactic cranial irradiation in extensive small-cell lung cancerBen Slotman, Corinne Faivre-Finn, Gijs Kramer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 21, 2009
EORTC-ROG expert opinion: radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction and the stomachOscar Matzinger, Erich Gerber, Zvi Bernstein, et al.
European Journal of Cancer (Oxford, England : 1990)|January 24, 2007
Quality assurance in breast cancer: EORTC experiences in the phase III trial on irradiation of the internal mammary nodesElena Musat, Philip Poortmans, Walter Van den Bogaert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2005
Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results--EORTC 22921Jean-François Bosset, Gilles Calais, Laurent Mineur, et al.
Journal of Clinical Epidemiology|April 18, 2022
Representativeness of trial participants: linking the EORTC boost-no boost trial to the Netherlands cancer registryAnouk Neven, Marissa C van Maaren, Kay Schreuder, et al.
JNCI Cancer Spectrum|July 31, 2019
A Systematic Review and Recommendation for Reporting of Surrogate Endpoint Evaluation Using Meta-analysesWanling Xie, Susan Halabi, Jayne F Tierney, et al.
The New England Journal of Medicine|September 15, 2006
Chemotherapy with preoperative radiotherapy in rectal cancerJean-François Bosset, Laurence Collette, Gilles Calais, et al.
European Urology|June 21, 2002
Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studiesMaurizio Brausi, Laurence Collette, Karlheinz Kurth, et al.
Pageof 16